These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16038892)

  • 1. Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects.
    Fiegenbaum M; da Silveira FR; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
    Clin Chim Acta; 2005 Dec; 362(1-2):182-8. PubMed ID: 16038892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ; Zhang SZ; He Y; Zhang L; Zhang KL; Huang DJ; Sun Y
    Chin Med J (Engl); 2004 Sep; 117(9):1288-92. PubMed ID: 15377415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
    Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
    Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
    Liu J; Zhao D; Liu S; Liu J; Qin LP; Wu ZS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):300-3. PubMed ID: 12820950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of APOE, CETP, and PCSK9 polymorphisms on simvastatin response in Thai hypercholesterolemic patients.
    Wanmasae S; Sirintronsopon W; Porntadavity S; Jeenduang N
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28851085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein.
    Borel P; Moussa M; Reboul E; Lyan B; Defoort C; Vincent-Baudry S; Maillot M; Gastaldi M; Darmon M; Portugal H; Lairon D; Planells R
    Br J Nutr; 2009 Mar; 101(5):680-7. PubMed ID: 18662427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
    J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.
    McPherson R
    Can J Clin Pharmacol; 1999; 6(2):85-90. PubMed ID: 10519734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
    Cenarro A; Artieda M; Gonzalvo C; Meriño-Ibarra E; Arístegui R; Gañán A; Díaz C; Sol JM; Pocoví M; Civeira F;
    Am Heart J; 2005 Dec; 150(6):1154-62. PubMed ID: 16338252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
    Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.
    Padmaja N; Ravindra Kumar M; Soya SS; Adithan C
    Clin Chim Acta; 2007 Jan; 375(1-2):140-6. PubMed ID: 16890925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between gene polymorphism at CETP locus and hyperlipidemia in the middle-aged and the elder].
    Zhao Y; Zhu W; Zhang Z; Li Y
    Wei Sheng Yan Jiu; 2004 Jan; 33(1):94-7. PubMed ID: 15098490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.
    Winkelmann BR; Hoffmann MM; Nauck M; Kumar AM; Nandabalan K; Judson RS; Boehm BO; Tall AR; Ruaño G; März W
    Pharmacogenomics J; 2003; 3(5):284-96. PubMed ID: 14583798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
    Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholesteryl ester transfer protein TAQ1B polymorphism in renal transplant patients.
    Zeybek U; Isbir T; Ergen HA; Yilmaz H; Hekim N; Akoglu E
    Transplant Proc; 2006 Jun; 38(5):1382-4. PubMed ID: 16797310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.